(Reuters) - Amag Pharmaceuticals Inc said on Thursday chief executive officer would step down and it plans to divest two of its women's health drugs, bowing to pressure from investor Caligan Partners ...
Family Capital Investment Group Adds Managing Director, Completes Investment in AMAG Technology, and Finalizes Add-On Acquisition for Quantum Design MINNEAPOLIS, Feb. 11, 2026 /PRNewswire/ -- Carlson ...
HAWTHORNE, Calif. — AMAG Technology has announced the appointment of Chris Meiter as its vice president of global business development for video solutions. Meiter comes from Salient Systems, a ...
'Deck chairs on the Titanic'?: AMAG's CEO departure, drug dumps may not right the ship, analyst says
After forfeiting two board seats and undertaking a strategic review, AMAG Pharmaceuticals is saying goodbye to its CEO and two of its drugs. But with another med likely being pulled from the market, ...
SAN DIEGO, Calif.—Polishing off the month of February, AMAG Technology held their 20 th annual Security Engineering Symposium (SES), focused on developing relationships, creative thinking and earning ...
WALTHAM, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has completed the sale of its rights to Intrarosa® (prasterone) to Millicent Pharma ...
Amid a proxy fight with activist investor Caligan Partners, AMAG Pharmaceuticals implored shareholders to stay the course on the drugmaker’s strategic vision. But with one of its drugs facing the ...
Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. This article is more than 10 years old. Investors eyeing a purchase of AMAG ...
WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief ...
Shares of AMAG Pharmaceuticals, Inc. (AMAG) soared 28.2% after it announced that it will be acquiring privately held Lumara Health Inc. for approximately $1 billion in order to diversify its portfolio ...
AMAG Pharmaceuticals, Inc. AMAG has entered into an agreement to acquire Connecticut-based privately held Perosphere Pharmaceuticals Inc., which will add the latter’s investigational candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results